2025版国家医保目录已发布！（附完整目录下载）

Core Insights - The 2025 National Medical Insurance Drug List has successfully added 114 new drugs, with 50 classified as innovative drugs, achieving an overall success rate of 88%, a significant increase from 76% in 2024 [4][8] - The new drug list will be implemented starting January 1, 2026, as announced during the 2025 Innovative Drug High-Quality Development Conference held in Guangzhou [4][5] Summary by Category National Medical Insurance Drug List - The 2025 National Medical Insurance Drug List includes drugs that address gaps in basic medical insurance coverage, such as treatments for triple-negative breast cancer, pancreatic cancer, and lung cancer [4][8] - The total number of drugs in the National Medical Insurance Drug List has increased to 3,253, comprising 1,857 Western medicines and 1,396 traditional Chinese medicines, enhancing coverage for key areas like cancer, chronic diseases, mental health, rare diseases, and pediatric medications [4][8] Commercial Health Insurance Innovative Drug List - The first edition of the commercial health insurance innovative drug list includes 19 new drugs, featuring CAR-T therapies for cancer treatment, as well as treatments for neuroblastoma, Gaucher disease, and Alzheimer's disease [4][8]